Data demonstrated multiple clinical benefits beyond linear growth— NDA supported by data from three randomized, double-blind, ...
Vanda Pharmaceuticals (VNDA) announced that a New Drug Application was submitted to the U.S. FDA requesting marketing approval of Bysanti for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback